INVESTIGATIONS OF MAMMALIAN AMINOPROPYLTRANSFERASES
INVESTIGATIONS OF MAMMALIAN AMINOPROPYLTRANSFERASES
批准号:
3273779
负责人:
ANTHONY E PEGG
金额:
$17.45万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-04-01 至 1996-03-31
关键词:
S adenosylmethionine acyltransferase alanine alkyltransferase aminoacyltransferase carbohydrate metabolism cell growth regulation enzyme activity enzyme induction /repression enzyme inhibitors enzyme mechanism enzyme substrate hamsters laboratory rabbit laboratory rat metabolism molecular cloning nucleic acid sequence nucleoside analog polyamines radiotracer tissue /cell culture transfection
中文摘要
研究的总体目标是:(a)提供一个详细的
了解合成反应的原理,
哺乳动物细胞中多胺的相互转化和去除;(B)
确定多胺的功能;和(c)使用这些信息
设计和测试多胺的抑制剂和拮抗剂,
有用的治疗性质。
这些研究将集中在三种酶上:亚精胺合酶和
精胺合酶,它们分别是氨丙基转移酶
负责亚精胺和精胺的合成,
亚精胺/精胺- N1-乙酰转移酶(SAT)是一种高度
诱导,速率控制酶的降解和排泄
这些多胺。 提出的实验是:调查
SAT的诱导机制,并评估SAT在调节
多胺含量与外排的关系,探讨多胺外排的机制
以及腐胺在保护细胞免受
目的:探讨精胺在低渗休克中的作用,
亚精胺合酶的结构、特异性和表达,
精胺合酶
在这些研究中使用的具体工具,
在这个项目的工作期间开发的,包括抗体,
三种酶,精脒合酶和SAT的cDNA克隆,特异性
氨丙基转移酶的抑制剂,具有
不同程度的取代天然多胺的能力,
诱导SAT的方法,以及分析多胺和
相关核苷如脱羧S-腺苷甲硫氨酸和
5 '-甲硫腺苷。 SAT抑制剂,可用于
正在研究其功能。 其旨在
获得精胺合酶的cDNA,这些酶的基因组克隆
并在E.大肠杆菌,
为研究提供充足的蛋白质。 还计划利用
具有诱导型启动子的适当质粒载体,以在大肠杆菌中表达SAT。
转染的哺乳动物细胞。
已知多胺对于哺乳动物细胞生长是必需的,
多胺拮抗剂已被证明具有作为
但这些影响被严格的
调节细胞多胺水平所带来的补偿
调整其合成、降解、吸收和
排泄 这些研究将确定化合物和方案,
最大限度地提高抗肿瘤策略的有效性,
细胞多胺含量
英文摘要
The overall objectives of the research are: (a) to provide a detailed
understanding of the reactions responsible for the synthesis,
interconversion and removal of polyamines in mammalian cells; (b) to
determine the functions of polyamines; and (c) to use this information
to design and test inhibitors and antagonists of polyamines which have
useful therapeutic properties.
The studies will be focussed on three enzymes; spermidine synthase and
spermine synthase, which are aminopropyltransferases respectively
responsible for the synthesis of spermidine and spermine, and
spermidine/spermine- N1-acetyltransferase (SAT) which is a highly
inducible, rate controlling enzyme in the degradation and excretion of
these polyamines. The experiments proposed are: to investigate the
mechanism of SAT induction and evaluate the role of SAT in regulating
polyamine content and efflux; to study the mechanism of polyamine efflux
and the possible role of putrescine in protecting cells against
hypotonic shock; to investigate the function of spermine; and to compare
the structure, specificity and expression of spermidine synthase and
spermine synthase.
Specific tools to be used in these studies, which have already been
developed during the work on this project, include antibodies to all
three enzymes, cDNA clones for spermidine synthase and SAT, specific
inhibitors for the aminopropyltransferases, polyamine analogs which have
varying degrees of ability to substitute for the natural polyamines and
to induce SAT, and methods for the analysis of the polyamines and
related nucleosides such as decarboxylated S-adenosylmethionine and
5'-methylthioadenosine. Inhibitors of SAT that can be used to
investigate its function are under development. It is intended to
obtain a cDNA for spermine synthase, genomic clones for these enzymes
and to express the mammalian enzymes in E. coli in order to generate
sufficient protein for the studies. It is also planned to use
appropriate plasmid vectors with inducible promoters to express SAT in
transfected mammalian cells.
Polyamines are known to be essential for mammalian cell growth and
polyamine antagonists have been demonstrated to have potential as
antineoplastic agents but these effects are counteracted by the strict
regulation of cellular polyamine levels brought about by compensatory
adjustments of their rate of synthesis, degradation, uptake and
excretion. These studies will identify compounds and protocols to
maximize the effectiveness of antitumor strategies which perturb
cellular polyamine content.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigations of Mammalian Aminopropyltransferases
-
批准号:7919710
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2009
-
负责人:ANTHONY E PEGG
-
依托单位:
CORE--IN VITRO TESTING OF AGT INHIBTORS
-
批准号:6347330
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2000
-
负责人:ANTHONY E PEGG
-
依托单位:
INTERACTION OF BG AND RELATED COMPOUNDS WITH AGT
-
批准号:6347325
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2000
-
负责人:ANTHONY E PEGG
-
依托单位:
INTERACTION OF BG AND RELATED COMPOUNDS WITH AGT
-
批准号:6203218
-
项目类别:
-
资助金额:$9.81万
-
财政年份:1999
-
负责人:ANTHONY E PEGG
-
依托单位:
CORE--IN VITRO TESTING OF AGT INHIBTORS
-
批准号:6203223
-
项目类别:
-
资助金额:$9.81万
-
财政年份:1999
-
负责人:ANTHONY E PEGG
-
依托单位:
INTERACTION OF BG AND RELATED COMPOUNDS WITH AGT
-
批准号:6102780
-
项目类别:
-
资助金额:$9.81万
-
财政年份:1998
-
负责人:ANTHONY E PEGG
-
依托单位:
CORE--IN VITRO TESTING OF AGT INHIBTORS
-
批准号:6102785
-
项目类别:
-
资助金额:$9.81万
-
财政年份:1998
-
负责人:ANTHONY E PEGG
-
依托单位:
INTERACTION OF BG AND RELATED COMPOUNDS WITH AGT
-
批准号:6237279
-
项目类别:
-
资助金额:$9.28万
-
财政年份:1997
-
负责人:ANTHONY E PEGG
-
依托单位:
CORE--IN VITRO TESTING OF AGT INHIBTORS
-
批准号:6237284
-
项目类别:
-
资助金额:$9.28万
-
财政年份:1997
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:2115465
-
项目类别:
-
资助金额:$17.93万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:6266799
-
项目类别:
-
资助金额:$23.97万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
Alkyltransferase Inhibitors for Cancer Chemotherapy
-
批准号:7418226
-
项目类别:
-
资助金额:$25.09万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:2895682
-
项目类别:
-
资助金额:$19.63万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:6906408
-
项目类别:
-
资助金额:$27.4万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:6633206
-
项目类别:
-
资助金额:$23.96万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:6513029
-
项目类别:
-
资助金额:$23.96万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
Alkyltransferase Inhibitors for Cancer Chemotherapy
-
批准号:7289705
-
项目类别:
-
资助金额:$25.09万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:6749441
-
项目类别:
-
资助金额:$27.41万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:2429932
-
项目类别:
-
资助金额:$18.47万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY
-
批准号:2712820
-
项目类别:
-
资助金额:$19.04万
-
财政年份:1996
-
负责人:ANTHONY E PEGG
-
依托单位:
海外基金